Registered entities
GILGAMESH PHARMACEUTICALS, INC.
Reg. No. 84-2552195United States
Social engagement
Social engagement: 11.3K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Prime Movers Lab, Y Combinator, Satori Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 14 | 70% |
| Private equity | 2 | 10% |
| Other / undisclosed | 4 | 20% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
5 Jan 2026 · CMC - Drug Substance professional · US-based
Based on job postings tracked across public sources.
Recent activity
6 Jan 2026
Product launch
Blixeprodil (GM-1020)
27 Aug 2025
Partnership
AbbVie